{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:44:06Z","timestamp":1769827446774,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,2,19]],"date-time":"2008-02-19T00:00:00Z","timestamp":1203379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00415-008-0738-5","type":"journal-article","created":{"date-parts":[[2008,2,18]],"date-time":"2008-02-18T14:42:48Z","timestamp":1203345768000},"page":"545-550","source":"Crossref","is-referenced-by-count":48,"title":["Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"255","author":[{"given":"J.","family":"Costa","sequence":"first","affiliation":[]},{"given":"M. L.","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"J.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"T.","family":"Evangelista","sequence":"additional","affiliation":[]},{"given":"M.","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"M.","family":"de Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,2,19]]},"reference":[{"key":"738_CR1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJM197010222831707","volume":"283","author":"Smith","year":"1970","unstructured":"Smith RA, Goode RL (1970) Current concepts: sialorrhoea. N Engl J Med 283:917\u2013918","journal-title":"N Engl J Med"},{"key":"738_CR2","first-page":"2628","volume":"69","author":"Hockstein","year":"2004","unstructured":"Hockstein NG, Samadi DS, Gendron K, Handler SD (2004) Sialorrhea: a management challenge. Am Fam Physician 69:2628\u20132634","journal-title":"Am Fam Physician"},{"key":"738_CR3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0306-9877(97)90103-1","volume":"48","author":"Bushara","year":"1997","unstructured":"Bushara KO (1997) Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment \u2013 botulinum toxin A injections of the parotid glands. Med Hypotheses 48:337\u2013339","journal-title":"Med Hypotheses"},{"key":"738_CR4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.54.1.244","volume":"54","author":"Pal","year":"2000","unstructured":"Pal PK, Calne DB, Calne S, Tsui JK (2000) Botulinum toxin A as treatment for drooling saliva in PD. Neurology 54(1):244\u2013247","journal-title":"Neurology"},{"key":"738_CR5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","volume":"61","author":"Lipp","year":"2003","unstructured":"Lipp A, Trottenberg T, Schink T, Kupsch A, Arnold G (2003) A randomized trial of botulinum toxin A for treatment of drooling. Neurology 61(9):1279\u20131281","journal-title":"Neurology"},{"key":"738_CR6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","volume":"18","author":"Mancini","year":"2003","unstructured":"Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C (2003) Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 18(6):685\u2013688","journal-title":"Mov Disord"},{"key":"738_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2003.10.012","volume":"106","author":"Dogu","year":"2004","unstructured":"Dogu O, Apaydin D, Sevim S, Talas DU, Aral M (2004) Ultrasound-guided versus \u2018blind\u2019 intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson\u2019s disease. Clin Neurol Neurosurg 106(2):93\u201396","journal-title":"Clin Neurol Neurosurg"},{"key":"738_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.20793","volume":"21","author":"Lagalla","year":"2006","unstructured":"Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG (2006) Botulinum toxin type A for drooling in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study. Mov Disord 21(5):704\u2013707","journal-title":"Mov Disord"},{"key":"738_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2006.11.015","volume":"253","author":"Nobrega","year":"2007","unstructured":"Nobrega AC, Rodrigues B, Torres AC, Enzo A, Melo A (2007) Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson\u2019s disease? J Neurol Sci 253(1\u20132):85\u201387","journal-title":"J Neurol Sci"},{"key":"738_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.69.1.121","volume":"69","author":"Giess","year":"2000","unstructured":"Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, Reiners C, Toyka KV (2000) Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 69(1):121\u2013123","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"738_CR11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.70.4.538","volume":"70","author":"Porta","year":"2001","unstructured":"Porta M, Gamba M, Bertacchi G, Vaj P (2001) Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 70(4):538\u2013540","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"738_CR12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1590\/S0034-72992005000500004","volume":"71","author":"Manrique","year":"2005","unstructured":"Manrique D (2005) Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis. Rev Bras Otorrinolaringol 71(5):556\u2013559","journal-title":"Rev Bras Otorrinolaringol"},{"key":"738_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mus.20545","volume":"34","author":"Verma","year":"2006","unstructured":"Verma A, Steele J (2006) Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve 34:235\u2013237","journal-title":"Muscle Nerve"},{"key":"738_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","volume":"62","author":"Ondo","year":"2004","unstructured":"Ondo WG, Hunter C, Moore W (2004) A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson\u2019s disease. Neurology 62(1):37\u201340","journal-title":"Neurology"},{"key":"738_CR15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","volume":"65","author":"Comella","year":"2005","unstructured":"Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S, Fan W; Dystonia Study Group (2005) Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 65:1423\u20131429","journal-title":"Neurology"},{"key":"738_CR16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s004550010012","volume":"15","author":"McHorney","year":"2000","unstructured":"McHorney CA, Bricker DE, Kramer AE, Rosenbek JC, Robbins J, Chignell KA, Logemann JA, Clarke C (2000) The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I Conceptual foundation and item development. Dysphagia 15(3):115\u2013121","journal-title":"Dysphagia"},{"key":"738_CR17","first-page":"A252","volume":"66","author":"Pappert","year":"2006","unstructured":"Pappert E J, Leong M S, Royal M An(2006) Botulinum toxin type B compared with type A in the treatment of toxin-naive patients with cervical dystonia: results from a randomized, double-blind study (abstract). Neurology 66(Suppl 2):A252","journal-title":"Neurology"},{"key":"738_CR18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/01.wnl.0000174433.76707.8c","volume":"65","author":"Tintner","year":"2005","unstructured":"Tintner R, Gross R, Winzer UF, Smalky KA, Jankovic J (2005) Autonomic function after botulinum toxin type A or B: A double-blind, randomized trial. Neurology 65:765\u2013767","journal-title":"Neurology"},{"key":"738_CR19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mds.10484","volume":"18","author":"Racette","year":"2003","unstructured":"Racette BA, Good L, Sagitto S, Perlmutter JS (2003) Botulinum toxin B reduces sialorrhea in parkinsonism. Mov Disord 18(9):1059\u20131061","journal-title":"Mov Disord"},{"key":"738_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.parkreldis.2006.05.005","volume":"13","author":"Contarino","year":"2007","unstructured":"Contarino MF, Pompili M, Tittoto P, Vanacore N, Sabatelli M, Cedrone A, Rapaccini GL, Gasbarrini G, Tonali PA, Bentivoglio AR (2007) Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson\u2019s disease. Parkinsonism Relat Disord 13(5):299\u2013303","journal-title":"Parkinsonism Relat Disord"},{"key":"738_CR21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s004050050129","volume":"256","author":"Ellies","year":"1999","unstructured":"Ellies M, Laskawi R, Gotz W, Arglebe C, Tormahlen G (1999) Immunohistochemical and morphometric investigations of the influence of botulinum toxin on the submandibular gland of the rat. Eur Arch Otorhinolaryngol 256:148\u2013152","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"738_CR22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-1331.2006.01447.x","volume":"13","author":"Tan","year":"2006","unstructured":"Tan EK (2006) Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations. Eur J Neurol 13(Suppl 1):60\u201364","journal-title":"Eur J Neurol"},{"key":"738_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/00220345550340021301","volume":"34","author":"Schneyer","year":"1955","unstructured":"Schneyer L (1955) Method for the collection of separate submaxillary and sublingual salivas in man. J Dent Res 34:257\u2013261","journal-title":"J Dent Res"},{"key":"738_CR24","first-page":"1","volume":"172","author":"Enfors","year":"1962","unstructured":"Enfors B (1962) The parotid and submandibular secretion in man. Acta Otolaryngol 172(Suppl):1\u201367","journal-title":"Acta Otolaryngol"},{"key":"738_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005537-200201000-00014","volume":"112","author":"Suskind","year":"2002","unstructured":"Suskind DL, Tilton A (2002) Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 112(1):73\u201381","journal-title":"Laryngoscope"},{"key":"738_CR26","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1097\/00005537-200410000-00033","volume":"114","author":"Ellies","year":"2004","unstructured":"Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R (2004) Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis. Laryngoscope 114:1856\u20131860","journal-title":"Laryngoscope"},{"key":"738_CR27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1353-8020(00)00073-0","volume":"Disord","author":"Friedman","year":"2001","unstructured":"Friedman A, Potulska A (2001) Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism Relat Disord (4):329\u2013332","journal-title":"Parkinsonism Relat"},{"key":"738_CR28","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1212\/01.wnl.0000249308.66959.43","volume":"26","author":"Jankovic","year":"2006","unstructured":"Jankovic J, Hunter C, Dolimbek BZ, Dolimbek GS, Adler CH, Brashear A, Comella CL, Gordon M, Riley DE, Sethi K, Singer C, Stacy M, Tarsy D, Atassi MZ (2006) Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology 26:2233\u20132235","journal-title":"Neurology"},{"key":"738_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF03033929","volume":"9","author":"Dressler","year":"2006","unstructured":"Dressler D, Eleopra R (2006) Clinical use of non-A botulinum toxins: botulinum toxin type B. Neurotox Res 9:121\u2013125","journal-title":"Neurotox Res"},{"key":"738_CR30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MOO.0b013e328011014a","volume":"14","author":"Lal","year":"2006","unstructured":"Lal D, Hotaling AJ (2006) Drooling. Curr Opin Otolaryngol Head Neck Surg 14:381\u2013386","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"738_CR31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tripleo.2005.08.018","volume":"101","author":"Meningaud","year":"2006","unstructured":"Meningaud JP, Pitak-Arnnop P, Chikhani L, Bertrand JC (2006) Drooling of saliva: a review of the etiology and management options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:48\u201357","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"738_CR32","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1517\/14656566.6.9.1551","volume":"6","author":"Potulska","year":"2005","unstructured":"Potulska A, Friedman A (2005) Controlling sialorrhoea: a review of available treatment options. Expert Opin Pharmacother 6:1551\u20131554","journal-title":"Expert Opin Pharmacother"},{"key":"738_CR33","first-page":"4S228","volume":"162","author":"Clavelou","year":"2006","unstructured":"Clavelou P, Guy N (2006) Symptomatic treatments in amyotrophic lateral sclerosis. Rev Neurol 162:4S228\u20134S234","journal-title":"Rev Neurol"},{"key":"738_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1345\/aph.1H381","volume":"41","author":"Benson","year":"2007","unstructured":"Benson J, Daugherty KK (2007) Botulinum toxin A in the treatment of sialorrhea. Ann Pharmacother 41(1):79\u201385","journal-title":"Ann Pharmacother"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0738-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-0738-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-0738-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:08:14Z","timestamp":1559056094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-0738-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,19]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-0738-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,19]]}}}